Clinical trial
Pro-omega-3, Reduction of Inflammation and Modulation of Prematurity
NCT03739463 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pro-omega-3, Reduction of Inflammation and Modulation of Prematurity
- Lead sponsor
- Université de Sherbrooke
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 3, 2018
- Completion date
- May 15, 2020
- Enrollment
- 70 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pprom